Brief: Avecho And Sandoz Enter Exclusive License And Development Agreement
03/03/2025 01:23
March 3 (Reuters) - Avecho Biotechnology Ltd AVE.AX: AVECHO AND SANDOZ ENTER EXCLUSIVE LICENSE AND DEVELOPMENT AGREEMENT TO COMMERCIALISE CBD FOR INSOMNIA IN AUSTRALIA AVECHO TO RECEIVE US$3M IN UPFRONT PAYMENT Further company coverage: AVE.AX ((Reuters.Briefs@thomsonreuters.com))
Recent news on Avecho Biotechnology
See all newsBrief: Avecho Biotechnology Seeks Trading Halt
Australia's Avecho Biotechnology falls on discounted placement
Brief: Avecho Biotechnology Raises A$2.5M Via Placement
Brief: Avecho And Sandoz Enter Exclusive License And Development Agreement
Brief: Avecho Biotechnology Seeks Trading Halt Pending Release Of Information About License And Development Agreement